MRKR — Marker Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $24.51m
- $6.92m
- $6.59m
- 17
- 28
- 44
- 19
Annual cashflow statement for Marker Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28.7 | -41.9 | -29.9 | -8.24 | -10.7 |
| Depreciation | |||||
| Non-Cash Items | 5.79 | 6.98 | 5.98 | -11 | 0.246 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.4 | 5.47 | -5.81 | 2.85 | -0.425 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -20 | -27.3 | -27 | -16.4 | -10.9 |
| Capital Expenditures | -9.25 | -3.13 | -4.95 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 18.7 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -9.25 | -3.13 | -4.95 | 18.7 | — |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 6.74 | 52.6 | 0.202 | 1.11 | 15 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -22.6 | 22.1 | -31.7 | 3.33 | 4.08 |